Frèdèrique Menzaghi
Keine laufenden Positionen mehr
Vermögen: 117 073 $ am 30.04.2024
Karriereverlauf von Frèdèrique Menzaghi
Ehemalige bekannte Positionen von Frèdèrique Menzaghi
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CARA THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2017 | 02.02.2024 |
Gründer | 02.07.2004 | 02.02.2024 | |
Psychogenics, Inc.
Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Corporate Officer/Principal | 01.01.2003 | 01.01.2004 |
ARENA PHARMACEUTICALS | Corporate Officer/Principal | 01.01.2003 | 01.01.2003 |
Sibia Neurosciences, Inc. | Gründer | - | - |
Corporate Officer/Principal | - | - | |
ELI LILLY AND COMPANY | Corporate Officer/Principal | - | - |
Ausbildung von Frèdèrique Menzaghi
Ecole des Mines de Nancy | Graduate Degree |
University of Strasbourg | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Frankreich | 3 |
Operativ
Corporate Officer/Principal | 4 |
Founder | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
CARA THERAPEUTICS, INC. | Health Technology |
ELI LILLY AND COMPANY | Health Technology |
Private Unternehmen | 3 |
---|---|
Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arena Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of novel drugs that target G protein-coupled receptors. It offers drugs for treatment in the field of cardiovascular, central nervous system, inflammatory, and metabolic diseases. The company was founded by Dominic P. Behan and Jack Lief on April 14, 1997 and is headquartered in Park City, UT. | Health Technology |
Psychogenics, Inc.
Psychogenics, Inc. Pharmaceuticals: MajorHealth Technology Psychogenics, Inc. specializes in preclinical neurobiology solutions. It offers animal models, behavioral tests, histology/immunohistochemistry, microdialysis/bioanalysis, electrophysiology, molecular biology and pharmacology. The company was founded by Eric Nestler, Benjamin S. Bunney and Daniel Goodman and is headquartered in Paramus, NJ. | Health Technology |
Sibia Neurosciences, Inc. | Health Technology |
- Börse
- Insiders
- Frèdèrique Menzaghi
- Erfahrung